FDA Device recall Z-2973-2018
Baby Quasar Plus, Light Therapy System, packaging, box, sleeve and user manual
- FDA Device
- Class II
- terminated
- Published 2018-09-12
On 2018-09-12 the FDA classified a Class II recall of Baby Quasar Plus, Light Therapy System, packaging, box, sleeve and user manual by Quasar Bio Tech, citing quasar did not receive FDA clearance for claims of collagen/elastin production as stated on the packaging and in the user manuals.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2973-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-06-29 |
| Published | 2018-09-12 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | Quasar Bio Tech |
| Distribution | US |
Product
Baby Quasar Plus, Light Therapy System, packaging, box, sleeve and user manual. Handheld Wrinkles Reduction Device.
Reason
Quasar did not receive FDA clearance for claims of collagen/elastin production as stated on the packaging and in the user manuals.
Identifiers
| upc | 091037461445 |
|---|---|
| code_info | Product Number DPA-023. UPC Code 0 91037 46144 5 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2973-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.